Diltiazem
CARTIA XT, Cardizem, Cardizem CD, Cardizem LA, Cartia, DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE, Matzim LA, TIADYLT ER, TIAZAC
Calcium Channel Blocker
NADAC/unit
$0.0528
No Shortage
Tier 1: 731.3%
24 Manufacturers
115 ANDAs
INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension.
vs. brand CARTIA XT: Generic saves up to 99% per unit
Active Shortages
2026-01-05 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-12-11 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-12-11 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-12-11 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-12-11 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS ELIZABETH LLCACTAVIS LABORATORIES FL INCALEMBIC PHARMACEUTICALS LTDAMTA LABS LTDAPOTEX INCBAUSCH HEALTH US LLCCHARTWELL RX SCIENCES LLCDR REDDYS LABORATORIES SAGLENMARK PHARMACEUTICALS LTDHIKMA PHARMACEUTICALS USA INCHOSPIRA INCHQ SPECIALTY PHARMA CORPMACLEODS PHARMACEUTICALS LTDMYLAN PHARMACEUTICALS INCNOVAST LABORATORIES LTDPH HEALTH LTDRISING PHARMA HOLDINGS INCSAGENT PHARMACEUTICALSSCIEGEN PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCTWI PHARMACEUTICALS INCUTOPIC PHARMACEUTICALS INCVALEANT PHARMACEUTICALS NORTH AMERICA LLCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.